Global RNA Based Therapeutics Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Based Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 qRT-PCR
1.2.3 RNA Interference (RNAi) Technologies
1.2.4 RNA Antisense
1.2.5 Inhibition
1.2.6 Microarrays
1.2.7 Labeling
1.2.8 Purification
1.3 Market by Application
1.3.1 Global RNA Based Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cardiovascular
1.3.3 Kidney Diseases
1.3.4 Oncology
1.3.5 Infectious Diseases
1.3.6 Metabolic Disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global RNA Based Therapeutics Market Perspective (2017-2028)
2.2 RNA Based Therapeutics Growth Trends by Region
2.2.1 RNA Based Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 RNA Based Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 RNA Based Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 RNA Based Therapeutics Market Dynamics
2.3.1 RNA Based Therapeutics Industry Trends
2.3.2 RNA Based Therapeutics Market Drivers
2.3.3 RNA Based Therapeutics Market Challenges
2.3.4 RNA Based Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Based Therapeutics Players by Revenue
3.1.1 Global Top RNA Based Therapeutics Players by Revenue (2017-2022)
3.1.2 Global RNA Based Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global RNA Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Based Therapeutics Revenue
3.4 Global RNA Based Therapeutics Market Concentration Ratio
3.4.1 Global RNA Based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Based Therapeutics Revenue in 2021
3.5 RNA Based Therapeutics Key Players Head office and Area Served
3.6 Key Players RNA Based Therapeutics Product Solution and Service
3.7 Date of Enter into RNA Based Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Based Therapeutics Breakdown Data by Type
4.1 Global RNA Based Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global RNA Based Therapeutics Forecasted Market Size by Type (2023-2028)
5 RNA Based Therapeutics Breakdown Data by Application
5.1 Global RNA Based Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global RNA Based Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America RNA Based Therapeutics Market Size (2017-2028)
6.2 North America RNA Based Therapeutics Market Size by Country (2017-2022)
6.3 North America RNA Based Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe RNA Based Therapeutics Market Size (2017-2028)
7.2 Europe RNA Based Therapeutics Market Size by Country (2017-2022)
7.3 Europe RNA Based Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Based Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific RNA Based Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific RNA Based Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America RNA Based Therapeutics Market Size (2017-2028)
9.2 Latin America RNA Based Therapeutics Market Size by Country (2017-2022)
9.3 Latin America RNA Based Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Based Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa RNA Based Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa RNA Based Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 ISIS pharmaceuticals (USA)
11.1.1 ISIS pharmaceuticals (USA) Company Detail
11.1.2 ISIS pharmaceuticals (USA) Business Overview
11.1.3 ISIS pharmaceuticals (USA) RNA Based Therapeutics Introduction
11.1.4 ISIS pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2017-2022)
11.1.5 ISIS pharmaceuticals (USA) Recent Development
11.2 Quark Pharmaceuticals (USA)
11.2.1 Quark Pharmaceuticals (USA) Company Detail
11.2.2 Quark Pharmaceuticals (USA) Business Overview
11.2.3 Quark Pharmaceuticals (USA) RNA Based Therapeutics Introduction
11.2.4 Quark Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2017-2022)
11.2.5 Quark Pharmaceuticals (USA) Recent Development
11.3 Alnylam Pharmaceuticals (USA)
11.3.1 Alnylam Pharmaceuticals (USA) Company Detail
11.3.2 Alnylam Pharmaceuticals (USA) Business Overview
11.3.3 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Introduction
11.3.4 Alnylam Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2017-2022)
11.3.5 Alnylam Pharmaceuticals (USA) Recent Development
11.4 Dicerna Pharmaceuticals (USA)
11.4.1 Dicerna Pharmaceuticals (USA) Company Detail
11.4.2 Dicerna Pharmaceuticals (USA) Business Overview
11.4.3 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Introduction
11.4.4 Dicerna Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2017-2022)
11.4.5 Dicerna Pharmaceuticals (USA) Recent Development
11.5 Tekmira Pharmaceuticals Corp. (Canada)
11.5.1 Tekmira Pharmaceuticals Corp. (Canada) Company Detail
11.5.2 Tekmira Pharmaceuticals Corp. (Canada) Business Overview
11.5.3 Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Introduction
11.5.4 Tekmira Pharmaceuticals Corp. (Canada) Revenue in RNA Based Therapeutics Business (2017-2022)
11.5.5 Tekmira Pharmaceuticals Corp. (Canada) Recent Development
11.6 Benitec Biopharma Limited (Australia)
11.6.1 Benitec Biopharma Limited (Australia) Company Detail
11.6.2 Benitec Biopharma Limited (Australia) Business Overview
11.6.3 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Introduction
11.6.4 Benitec Biopharma Limited (Australia) Revenue in RNA Based Therapeutics Business (2017-2022)
11.6.5 Benitec Biopharma Limited (Australia) Recent Development
11.7 Genzyme Corporation (USA)
11.7.1 Genzyme Corporation (USA) Company Detail
11.7.2 Genzyme Corporation (USA) Business Overview
11.7.3 Genzyme Corporation (USA) RNA Based Therapeutics Introduction
11.7.4 Genzyme Corporation (USA) Revenue in RNA Based Therapeutics Business (2017-2022)
11.7.5 Genzyme Corporation (USA) Recent Development
11.8 Silence Therapeutics PLC (UK)
11.8.1 Silence Therapeutics PLC (UK) Company Detail
11.8.2 Silence Therapeutics PLC (UK) Business Overview
11.8.3 Silence Therapeutics PLC (UK) RNA Based Therapeutics Introduction
11.8.4 Silence Therapeutics PLC (UK) Revenue in RNA Based Therapeutics Business (2017-2022)
11.8.5 Silence Therapeutics PLC (UK) Recent Development
11.9 Cenix BioScience GmbH (Germany)
11.9.1 Cenix BioScience GmbH (Germany) Company Detail
11.9.2 Cenix BioScience GmbH (Germany) Business Overview
11.9.3 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Introduction
11.9.4 Cenix BioScience GmbH (Germany) Revenue in RNA Based Therapeutics Business (2017-2022)
11.9.5 Cenix BioScience GmbH (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global RNA Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of qRT-PCR
Table 3. Key Players of RNA Interference (RNAi) Technologies
Table 4. Key Players of RNA Antisense
Table 5. Key Players of Inhibition
Table 6. Key Players of Microarrays
Table 7. Key Players of Labeling
Table 8. Key Players of Purification
Table 9. Global RNA Based Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global RNA Based Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global RNA Based Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global RNA Based Therapeutics Market Share by Region (2017-2022)
Table 13. Global RNA Based Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global RNA Based Therapeutics Market Share by Region (2023-2028)
Table 15. RNA Based Therapeutics Market Trends
Table 16. RNA Based Therapeutics Market Drivers
Table 17. RNA Based Therapeutics Market Challenges
Table 18. RNA Based Therapeutics Market Restraints
Table 19. Global RNA Based Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global RNA Based Therapeutics Market Share by Players (2017-2022)
Table 21. Global Top RNA Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Based Therapeutics as of 2021)
Table 22. Ranking of Global Top RNA Based Therapeutics Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by RNA Based Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players RNA Based Therapeutics Product Solution and Service
Table 26. Date of Enter into RNA Based Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global RNA Based Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global RNA Based Therapeutics Revenue Market Share by Type (2017-2022)
Table 30. Global RNA Based Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global RNA Based Therapeutics Revenue Market Share by Type (2023-2028)
Table 32. Global RNA Based Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global RNA Based Therapeutics Revenue Market Share by Application (2017-2022)
Table 34. Global RNA Based Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global RNA Based Therapeutics Revenue Market Share by Application (2023-2028)
Table 36. North America RNA Based Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America RNA Based Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe RNA Based Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe RNA Based Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific RNA Based Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific RNA Based Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America RNA Based Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America RNA Based Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa RNA Based Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa RNA Based Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 46. ISIS pharmaceuticals (USA) Company Detail
Table 47. ISIS pharmaceuticals (USA) Business Overview
Table 48. ISIS pharmaceuticals (USA) RNA Based Therapeutics Product
Table 49. ISIS pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 50. ISIS pharmaceuticals (USA) Recent Development
Table 51. Quark Pharmaceuticals (USA) Company Detail
Table 52. Quark Pharmaceuticals (USA) Business Overview
Table 53. Quark Pharmaceuticals (USA) RNA Based Therapeutics Product
Table 54. Quark Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 55. Quark Pharmaceuticals (USA) Recent Development
Table 56. Alnylam Pharmaceuticals (USA) Company Detail
Table 57. Alnylam Pharmaceuticals (USA) Business Overview
Table 58. Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product
Table 59. Alnylam Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 60. Alnylam Pharmaceuticals (USA) Recent Development
Table 61. Dicerna Pharmaceuticals (USA) Company Detail
Table 62. Dicerna Pharmaceuticals (USA) Business Overview
Table 63. Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product
Table 64. Dicerna Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 65. Dicerna Pharmaceuticals (USA) Recent Development
Table 66. Tekmira Pharmaceuticals Corp. (Canada) Company Detail
Table 67. Tekmira Pharmaceuticals Corp. (Canada) Business Overview
Table 68. Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Product
Table 69. Tekmira Pharmaceuticals Corp. (Canada) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Tekmira Pharmaceuticals Corp. (Canada) Recent Development
Table 71. Benitec Biopharma Limited (Australia) Company Detail
Table 72. Benitec Biopharma Limited (Australia) Business Overview
Table 73. Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product
Table 74. Benitec Biopharma Limited (Australia) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Benitec Biopharma Limited (Australia) Recent Development
Table 76. Genzyme Corporation (USA) Company Detail
Table 77. Genzyme Corporation (USA) Business Overview
Table 78. Genzyme Corporation (USA) RNA Based Therapeutics Product
Table 79. Genzyme Corporation (USA) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Genzyme Corporation (USA) Recent Development
Table 81. Silence Therapeutics PLC (UK) Company Detail
Table 82. Silence Therapeutics PLC (UK) Business Overview
Table 83. Silence Therapeutics PLC (UK) RNA Based Therapeutics Product
Table 84. Silence Therapeutics PLC (UK) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Silence Therapeutics PLC (UK) Recent Development
Table 86. Cenix BioScience GmbH (Germany) Company Detail
Table 87. Cenix BioScience GmbH (Germany) Business Overview
Table 88. Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product
Table 89. Cenix BioScience GmbH (Germany) Revenue in RNA Based Therapeutics Business (2017-2022) & (US$ Million)
Table 90. Cenix BioScience GmbH (Germany) Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of FiguresFigure 1. Global RNA Based Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. qRT-PCR Features
Figure 3. RNA Interference (RNAi) Technologies Features
Figure 4. RNA Antisense Features
Figure 5. Inhibition Features
Figure 6. Microarrays Features
Figure 7. Labeling Features
Figure 8. Purification Features
Figure 9. Global RNA Based Therapeutics Market Share by Application in 2021 & 2028
Figure 10. Cardiovascular Case Studies
Figure 11. Kidney Diseases Case Studies
Figure 12. Oncology Case Studies
Figure 13. Infectious Diseases Case Studies
Figure 14. Metabolic Disorders Case Studies
Figure 15. RNA Based Therapeutics Report Years Considered
Figure 16. Global RNA Based Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global RNA Based Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global RNA Based Therapeutics Market Share by Region: 2021 VS 2028
Figure 19. Global RNA Based Therapeutics Market Share by Players in 2021
Figure 20. Global Top RNA Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Based Therapeutics as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by RNA Based Therapeutics Revenue in 2021
Figure 22. North America RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America RNA Based Therapeutics Market Share by Country (2017-2028)
Figure 24. United States RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe RNA Based Therapeutics Market Share by Country (2017-2028)
Figure 28. Germany RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific RNA Based Therapeutics Market Share by Region (2017-2028)
Figure 36. China RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America RNA Based Therapeutics Market Share by Country (2017-2028)
Figure 44. Mexico RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa RNA Based Therapeutics Market Share by Country (2017-2028)
Figure 48. Turkey RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Saudi Arabia RNA Based Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. ISIS pharmaceuticals (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 51. Quark Pharmaceuticals (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 52. Alnylam Pharmaceuticals (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 53. Dicerna Pharmaceuticals (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 54. Tekmira Pharmaceuticals Corp. (Canada) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 55. Benitec Biopharma Limited (Australia) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 56. Genzyme Corporation (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 57. Silence Therapeutics PLC (UK) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 58. Cenix BioScience GmbH (Germany) Revenue Growth Rate in RNA Based Therapeutics Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed